Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

MedChemComm

Showing results (361-370 of 801) with videos related to

Pageof 81
Sort By:
Medchemcomm|March 6, 2020
Design of a MUC1-based tricomponent vaccine adjuvanted with FSL-1 for cancer immunotherapyMingjing Li, Zhaoyu Wang, Bocheng Yan, et al.
Medchemcomm|January 28, 2014
The structure-activity relationships of L3MBTL3 inhibitors: flexibility of the dimer interfaceMichelle A Camerino, Nan Zhong, Aiping Dong, et al.
Medchemcomm|September 9, 2020
Synthesis and characterization of a novel <sup>18</sup>F-labeled 2,5-diarylnicotinamide derivative targeting orexin 2 receptorHiroyuki Watanabe, Naoki Matsushita, Yoichi Shimizu, et al.
Medchemcomm|December 10, 2019
Synergistic effect of tolfenamic acid and glycyrrhizic acid on TPA-induced skin inflammation in miceWenfeng Liu, Shun Huang, Yonglian Li, et al.
Medchemcomm|March 25, 2020
Structural modification of azolylacryloyl derivatives yields a novel class of covalent modifiers of hemoglobin as potential antisickling agentsA M Omar, T David, P P Pagare, et al.
Medchemcomm|January 11, 2019
The transition to magic bullets - transition state analogue drug designGary B Evans, Vern L Schramm, Peter C Tyler
Medchemcomm|November 26, 2019
Synthesis and structure-activity relationship studies of IgG-binding peptides focused on the C-terminal histidine residueKyohei Muguruma, Mayu Ito, Akane Fukuda, et al.
Medchemcomm|December 6, 2019
Quinolone antibioticsThu D M Pham, Zyta M Ziora, Mark A T Blaskovich
Medchemcomm|December 6, 2019
Resisting resistance: gearing up for warAurijit Sarkar, Sylvie Garneau-Tsodikova
Medchemcomm|September 4, 2020
A small molecule drug conjugate (SMDC) of DUPA and a duocarmycin built on the solid phaseAndrew Michael Beekman, Marco M D Cominetti, Oliver Charles Cartwright, et al.
Pageof 81

Showing results (361-370 of 801) with videos related to

Sort By:
Pageof 81
Medchemcomm|March 6, 2020
Design of a MUC1-based tricomponent vaccine adjuvanted with FSL-1 for cancer immunotherapyMingjing Li, Zhaoyu Wang, Bocheng Yan, et al.
Medchemcomm|January 28, 2014
The structure-activity relationships of L3MBTL3 inhibitors: flexibility of the dimer interfaceMichelle A Camerino, Nan Zhong, Aiping Dong, et al.
Medchemcomm|September 9, 2020
Synthesis and characterization of a novel <sup>18</sup>F-labeled 2,5-diarylnicotinamide derivative targeting orexin 2 receptorHiroyuki Watanabe, Naoki Matsushita, Yoichi Shimizu, et al.
Medchemcomm|December 10, 2019
Synergistic effect of tolfenamic acid and glycyrrhizic acid on TPA-induced skin inflammation in miceWenfeng Liu, Shun Huang, Yonglian Li, et al.
Medchemcomm|March 25, 2020
Structural modification of azolylacryloyl derivatives yields a novel class of covalent modifiers of hemoglobin as potential antisickling agentsA M Omar, T David, P P Pagare, et al.
Medchemcomm|January 11, 2019
The transition to magic bullets - transition state analogue drug designGary B Evans, Vern L Schramm, Peter C Tyler
Medchemcomm|November 26, 2019
Synthesis and structure-activity relationship studies of IgG-binding peptides focused on the C-terminal histidine residueKyohei Muguruma, Mayu Ito, Akane Fukuda, et al.
Medchemcomm|December 6, 2019
Quinolone antibioticsThu D M Pham, Zyta M Ziora, Mark A T Blaskovich
Medchemcomm|December 6, 2019
Resisting resistance: gearing up for warAurijit Sarkar, Sylvie Garneau-Tsodikova
Medchemcomm|September 4, 2020
A small molecule drug conjugate (SMDC) of DUPA and a duocarmycin built on the solid phaseAndrew Michael Beekman, Marco M D Cominetti, Oliver Charles Cartwright, et al.
Pageof 81